John Valliant insider trades: Fusion Pharmaceuticals (FUSN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where John reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 27, 2022 | FUSN | ↓ Sell10b5-1 | 8,694 | $6.04 | $53K | Direct | Apr 27, 2022 (0d) |
| Apr 21, 2022 | FUSN | ↓ Sell10b5-1 | 1,289 | $6.01 | $8K | Direct | Apr 22, 2022 (1d) |
| Apr 13, 2022 | FUSN | ↓ Sell10b5-1 | 32,849 | $6.87 | $226K | Direct | Apr 13, 2022 (0d) |
| Apr 8, 2022 | FUSN | ↓ Sell10b5-1 | 2,181 | $7.55 | $16K | Direct | Apr 8, 2022 (0d) |
| Apr 5, 2022 | FUSN | ↓ Sell10b5-1 | 3,800 | $7.72 | $29K | Direct | Apr 5, 2022 (0d) |
| Mar 30, 2022 | FUSN | ↓ Sell10b5-1 | 300 | $7.52 | $2K | Direct | Apr 1, 2022 (2d) |
| Mar 29, 2022 | FUSN | ↓ Sell10b5-1 | 10,300 | $7.54 | $78K | Direct | Mar 29, 2022 (0d) |
| Mar 23, 2022 | FUSN | ↓ Sell10b5-1 | 4,800 | $7.52 | $36K | Direct | Mar 24, 2022 (1d) |
| Mar 21, 2022 | FUSN | ↓ Sell10b5-1 | 3,604 | $7.53 | $27K | Direct | Mar 21, 2022 (0d) |
| Mar 16, 2022 | FUSN | ↓ Sell10b5-1 | 1,500 | $6.97 | $10K | Direct | Mar 16, 2022 (0d) |
| Mar 11, 2022 | FUSN | ↓ Sell10b5-1 | 2,822 | $7.03 | $20K | Direct | Mar 14, 2022 (3d) |
| Mar 8, 2022 | FUSN | ↓ Sell10b5-1 | 14,504 | $7.17 | $104K | Direct | Mar 8, 2022 (0d) |
| Mar 3, 2022 | FUSN | ↓ Sell10b5-1 | 27,593 | $7.44 | $205K | Direct | Mar 3, 2022 (0d) |
| Feb 28, 2022 | FUSN | ↓ Sell10b5-1 | 13,752 | $7.50 | $103K | Direct | Feb 28, 2022 (0d) |
| Feb 23, 2022 | FUSN | ↓ Sell10b5-1 | 38,297 | $7.79 | $298K | Direct | Feb 23, 2022 (0d) |
| Feb 17, 2022 | FUSN | ↓ Sell10b5-1 | 47,502 | $8.08 | $384K | Direct | Feb 17, 2022 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About John Valliant's insider trades
John Valliant is Chief Executive Officer at Fusion Pharmaceuticals (FUSN). Since Feb 17, 2022, John has reported no open-market purchases and 16 sales worth $1.6M on SEC Form 4. There have been no open-market trades in the last 12 months.
16 sales (100% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (5 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every FUSN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.